From the Department of Diagnostic and Interventional Radiology and Nuclear Medicine (C.R., A.L., I.R., G.A., B.P.S., P.B.) and I. Department of Medicine (F.P., J.K.), University Medical Center Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany; Institute of Multiphase Flows, Hamburg University of Technology, Hamburg, Germany (M.H., M.I., M.S.); and Departments of Radiology, Medical Physics, Biomedical Engineering, Medicine, and Emergency Medicine, University of Wisconsin-Madison, Madison, Wis (S.B.R.).
Radiology. 2024 Oct;313(1):e232989. doi: 10.1148/radiol.232989.
Background Transjugular intrahepatic portosystemic shunt (TIPS) dysfunction in patients with liver cirrhosis and recurrent symptoms of portal hypertension is primarily assessed with US and confirmed with invasive catheter venography, which can be used to measure the portosystemic pressure gradient (PSPG) to identify TIPS-refractory portal hypertension. To avoid the risks and costs of invasive catheter venography, noninvasive PSPG evaluation strategies are needed. Purpose To demonstrate the feasibility of the combination of four-dimensional (4D) flow MRI with computational fluid dynamics (CFD) for noninvasive PSPG assessment in participants with cirrhosis and TIPS. Materials and Methods Abdominal 4D flow MRI was performed prospectively in participants with cirrhosis and TIPS between January 2019 and September 2020. Flow rates were measured within the TIPS and inferior vena cava (IVC). The portal vein (PV), TIPS, right hepatic vein, and IVC were segmented on MRI scans to create a CFD mesh. The PV and infrahepatic IVC were defined as inflows for 4D flow MRI-derived flow rates. The suprahepatic IVC was defined as the outflow. CFD simulations were used to noninvasively estimate PSPG as the difference between the simulated pressures in the PV and suprahepatic IVC. Invasive venographic measurements of the PSPG served as the reference standard, and Pearson correlation analysis was conducted to evaluate the relationship between noninvasive estimates and invasive measurements. Results In all 20 participants with cirrhosis (mean age, 58 years ± 9 [SD]; 11 men), 4D flow MRI-based CFD simulations enabled visualization of flow velocities and pressure distributions within the segmented vasculature and TIPS. Noninvasive estimates and invasive measures of PSPG were strongly correlated ( = 0.77; < .001). The 4D flow MRI-based CFD simulations correctly classified the presence or absence of a post-TIPS PSPG greater than 12 mm Hg in 16 of 20 participants (80%). Conclusion The combination of 4D flow MRI and CFD was feasible for noninvasive PSPG assessment in participants with cirrhosis, portal hypertension, and TIPS. © RSNA, 2024 See also the editorial by Motosugi and Watanabe in this issue.
肝硬化患者经颈静脉肝内门体分流术(TIPS)功能障碍并伴有门静脉高压症复发症状时,主要采用超声检查进行评估,并通过有创性导管静脉造影进行确认,该方法可用于测量门体系统压力梯度(PSPG),以确定 TIPS 难治性门静脉高压症。为避免有创性导管静脉造影的风险和费用,需要采用非侵入性 PSPG 评估策略。
旨在展示四维(4D)流动 MRI 结合计算流体动力学(CFD)用于评估肝硬化伴 TIPS 患者非侵入性 PSPG 的可行性。
本研究前瞻性纳入 2019 年 1 月至 2020 年 9 月期间患有肝硬化伴 TIPS 的患者,进行腹部 4D 流动 MRI 检查。在 TIPS 内和下腔静脉(IVC)内测量流速。在 MRI 扫描上对门静脉(PV)、TIPS、肝右静脉和 IVC 进行分割,以创建 CFD 网格。将 PV 和肝下段 IVC 定义为 4D 流动 MRI 衍生流速的流入,将肝上段 IVC 定义为流出。使用 CFD 模拟技术无创性估计 PSPG,即模拟 PV 和肝上段 IVC 之间的压力差。将有创性静脉造影测量的 PSPG 作为参考标准,并进行 Pearson 相关性分析,以评估无创性估计值与有创性测量值之间的关系。
在所有 20 名患有肝硬化的患者(平均年龄,58 岁±9[标准差];11 名男性)中,基于 4D 流动 MRI 的 CFD 模拟能够可视化分段血管和 TIPS 内的流速和压力分布。非侵入性估计值和有创性测量值的 PSPG 具有很强的相关性(r = 0.77;P <.001)。基于 4D 流动 MRI 的 CFD 模拟正确分类了 20 名患者中 16 名(80%)存在或不存在 TIPS 后 PSPG 大于 12mmHg 的情况。
4D 流动 MRI 结合 CFD 可用于评估肝硬化、门静脉高压症和 TIPS 患者的非侵入性 PSPG。